Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Port

Showing results (181-190 of 200) with videos related to

Pageof 20
Sort By:
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 3, 2011
Preoperative taxane-based chemotherapy and celecoxib for carcinoma of the esophagus and gastroesophageal junction: results of a phase 2 trialNasser K Altorki, Paul Christos, Jeff L Port, et al.
Journal of the American Geriatrics Society|November 9, 2005
Mortality and adverse health events in newly admitted nursing home residents with and without dementiaJay Magaziner, Sheryl Zimmerman, Ann L Gruber-Baldini, et al.
Brachytherapy|June 7, 2011
Cesium-131 permanent seed brachytherapy: dosimetric evaluation and radiation exposure to surgeons, radiation oncologists, and staffBhupesh Parashar, A Gabriella Wernicke, Al Pavese, et al.
The American Journal of Sports Medicine|February 18, 2022
Utility of VOMS, SCAT3, and ImPACT Baseline Evaluations for Acute Concussion Identification in Collegiate Athletes: Findings From the NCAA-DoD Concussion Assessment, Research and Education (CARE) ConsortiumLyndsey M Ferris, Anthony P Kontos, Shawn R Eagle, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 16, 2003
Celecoxib, a selective cyclo-oxygenase-2 inhibitor, enhances the response to preoperative paclitaxel and carboplatin in early-stage non-small-cell lung cancerN K Altorki, R S Keresztes, J L Port, et al.
Journal of Rehabilitation Medicine|October 2, 2015
Effectiveness of the Restore4Stroke self-management intervention "Plan ahead!": A randomized controlled trial in stroke patients and partnersNienke S Tielemans, Johanna M A Visser-Meily, Vera P M Schepers, et al.
The Annals of Thoracic Surgery|January 1, 2016
Incidence and Factors Associated With Hospital Readmission After Pulmonary LobectomyBrendon M Stiles, Andrea Poon, Gregory P Giambrone, et al.
Cancer Prevention Research (Philadelphia, Pa.)|January 14, 2009
NAD+-dependent 15-hydroxyprostaglandin dehydrogenase regulates levels of bioactive lipids in non-small cell lung cancerDuncan Hughes, Taisuke Otani, Peiying Yang, et al.
The Journal of Thoracic and Cardiovascular Surgery|July 20, 2025
Neoadjuvant nonablative stereotactic body radiotherapy plus immunotherapy yields similar pathologic response as chemoimmunotherapy in non-small cell lung cancerDan Jones, Abu Nasar, Jonathan Villena-Vargas, et al.
The Journal of Thoracic and Cardiovascular Surgery|March 5, 2009
CXCL12 and CXCR4 in adenocarcinoma of the lung: association with metastasis and survivalPatrick L Wagner, Elizabeth Hyjek, Madeline F Vazquez, et al.
Pageof 20

Showing results (181-190 of 200) with videos related to

Sort By:
Pageof 20
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 3, 2011
Preoperative taxane-based chemotherapy and celecoxib for carcinoma of the esophagus and gastroesophageal junction: results of a phase 2 trialNasser K Altorki, Paul Christos, Jeff L Port, et al.
Journal of the American Geriatrics Society|November 9, 2005
Mortality and adverse health events in newly admitted nursing home residents with and without dementiaJay Magaziner, Sheryl Zimmerman, Ann L Gruber-Baldini, et al.
Brachytherapy|June 7, 2011
Cesium-131 permanent seed brachytherapy: dosimetric evaluation and radiation exposure to surgeons, radiation oncologists, and staffBhupesh Parashar, A Gabriella Wernicke, Al Pavese, et al.
The American Journal of Sports Medicine|February 18, 2022
Utility of VOMS, SCAT3, and ImPACT Baseline Evaluations for Acute Concussion Identification in Collegiate Athletes: Findings From the NCAA-DoD Concussion Assessment, Research and Education (CARE) ConsortiumLyndsey M Ferris, Anthony P Kontos, Shawn R Eagle, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 16, 2003
Celecoxib, a selective cyclo-oxygenase-2 inhibitor, enhances the response to preoperative paclitaxel and carboplatin in early-stage non-small-cell lung cancerN K Altorki, R S Keresztes, J L Port, et al.
Journal of Rehabilitation Medicine|October 2, 2015
Effectiveness of the Restore4Stroke self-management intervention "Plan ahead!": A randomized controlled trial in stroke patients and partnersNienke S Tielemans, Johanna M A Visser-Meily, Vera P M Schepers, et al.
The Annals of Thoracic Surgery|January 1, 2016
Incidence and Factors Associated With Hospital Readmission After Pulmonary LobectomyBrendon M Stiles, Andrea Poon, Gregory P Giambrone, et al.
Cancer Prevention Research (Philadelphia, Pa.)|January 14, 2009
NAD+-dependent 15-hydroxyprostaglandin dehydrogenase regulates levels of bioactive lipids in non-small cell lung cancerDuncan Hughes, Taisuke Otani, Peiying Yang, et al.
The Journal of Thoracic and Cardiovascular Surgery|July 20, 2025
Neoadjuvant nonablative stereotactic body radiotherapy plus immunotherapy yields similar pathologic response as chemoimmunotherapy in non-small cell lung cancerDan Jones, Abu Nasar, Jonathan Villena-Vargas, et al.
The Journal of Thoracic and Cardiovascular Surgery|March 5, 2009
CXCL12 and CXCR4 in adenocarcinoma of the lung: association with metastasis and survivalPatrick L Wagner, Elizabeth Hyjek, Madeline F Vazquez, et al.
Pageof 20